Nasdaq Etf Buy Hold or Sell Recommendation

IBB
 Etf
  

USD 132.52  1.23  0.94%   

Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Nasdaq Biotechnology Ishares is 'Buy'. Macroaxis provides Nasdaq Biotechnology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IBB positions. The advice algorithm takes into account all of Nasdaq Biotechnology's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Nasdaq Biotechnology's buy-and-hold perspective. Please see Nasdaq Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual funds such as Nasdaq and provide practical buy, sell, or hold recommendation based on selected investing horizon and risk tolerance towards Nasdaq Biotechnology Ishares.

Execute Nasdaq Biotechnology Buy or Sell Advice

The Nasdaq recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nasdaq Biotechnology Ishares. Macroaxis does not own or have any residual interests in Nasdaq Biotechnology Ishares or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nasdaq Biotechnology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nasdaq BiotechnologyBuy Nasdaq Biotechnology
Buy

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds of Distress

Close to AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Not AvailableDetails
For the selected time horizon Nasdaq Biotechnology Ishares has a Risk Adjusted Performance of 0.1984, Jensen Alpha of 0.212, Total Risk Alpha of 0.1797, Sortino Ratio of 0.0996 and Treynor Ratio of 0.2672
Macroaxis provides trade recommendations on Nasdaq Biotechnology to complement and cross-verify current analyst consensus on Nasdaq Biotechnology. Our advice engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. Use Nasdaq Biotechnology Ishares five year return, as well as the relationship between the net asset and equity positions weight to ensure your buy or sell decision on Nasdaq Biotechnology is adequate.

Nasdaq Biotechnology Trading Alerts and Improvement Suggestions

The fund retains 99.91% of its assets under management (AUM) in equities

Nasdaq Biotechnology Returns Distribution Density

The distribution of Nasdaq Biotechnology's historical returns is an attempt to chart the future uncertainty of Nasdaq Biotechnology's future price movements. The chart of the probability distribution of Nasdaq Biotechnology stock daily returns describes the distribution of returns around its average expected value. We use Nasdaq Biotechnology Ishares price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nasdaq Biotechnology returns is essential to provide solid investment advice for Nasdaq Biotechnology stock.
Mean Return0.30Value At Risk-3.07
Potential Upside3.37Standard Deviation1.92
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nasdaq Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nasdaq Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nasdaq Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nasdaq Biotechnology Ishares backward and forwards among themselves. Nasdaq Biotechnology's institutional investor refers to the entity that pools money to purchase Nasdaq Biotechnology's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Bank Of America CorpFund Units11.2 M1.3 B
Ubs Group AgCall Options300 K35.3 M
Note, although Nasdaq Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nasdaq Biotechnology Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nasdaq Biotechnology or iShares sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nasdaq Biotechnology stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nasdaq stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.21
β
Beta against DOW1.08
σ
Overall volatility
1.83
Ir
Information ratio 0.11

Nasdaq Biotechnology Volatility Alert

Nasdaq Biotechnology Ishares currently demonstrates below-average downside deviation. It has Information Ratio of 0.11 and Jensen Alpha of 0.21. However, we advise investors to further question Nasdaq Biotechnology Ishares expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nasdaq Biotechnology's etf risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nasdaq Biotechnology's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Nasdaq Biotechnology Implied Volatility

Nasdaq Biotechnology's implied volatility" href="/stock-options/IBB/Nasdaq-Biotechnology-Ishares">Nasdaq Biotechnology's implied volatility exposes the market's sentiment of Nasdaq Biotechnology Ishares stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nasdaq Biotechnology's implied volatility" href="/stock-options/IBB/Nasdaq-Biotechnology-Ishares">Nasdaq Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nasdaq Biotechnology stock will not fluctuate a lot when Nasdaq Biotechnology's options" href="/stock-options/IBB/Nasdaq-Biotechnology-Ishares">Nasdaq Biotechnology's options are near their expiration.

Nasdaq Biotechnology Fundamentals Vs Peers

Comparing Nasdaq Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nasdaq Biotechnology's direct or indirect competition across all of the common fundamentals between Nasdaq Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nasdaq Biotechnology or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Nasdaq Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nasdaq Biotechnology by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Nasdaq Biotechnology to competition
FundamentalsNasdaq BiotechnologyPeer Average
Price to Earning3.14 X3.15 X
Price to Book3.39 X0.39 X
Price to Sales4.94 X0.33 X
One Year Return(25.74) %(0.97) %
Three Year Return5.46 %3.23 %
Five Year Return3.19 %1.12 %
Ten Year Return10.93 %1.20 %
Net Asset7.53 B2.29 B
Last Dividend Paid0.390.14
Equity Positions Weight99.91 %52.82 %

Nasdaq Biotechnology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nasdaq . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution18034.44
Daily Balance Of Power0.691
Rate Of Daily Change1.01
Day Median Price131.98
Day Typical Price132.16
Market Facilitation Index0.0
Price Action Indicator1.16

About Nasdaq Biotechnology Buy or Sell Advice

When is the right time to buy or sell Nasdaq Biotechnology Ishares? Buying financial instruments such as Nasdaq Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Nasdaq Biotechnology investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Nasdaq Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Toys Thematic Idea Now

Toys
Toys Theme
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
View All  Next Launch
Please see Nasdaq Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Nasdaq Biotechnology information on this page should be used as a complementary analysis to other Nasdaq Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Nasdaq Etf analysis

When running Nasdaq Biotechnology price analysis, check to measure Nasdaq Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasdaq Biotechnology is operating at the current time. Most of Nasdaq Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nasdaq Biotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nasdaq Biotechnology's price. Additionally, you may evaluate how the addition of Nasdaq Biotechnology to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
The market value of Nasdaq Biotechnology is measured differently than its book value, which is the value of Nasdaq that is recorded on the company's balance sheet. Investors also form their own opinion of Nasdaq Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Nasdaq Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nasdaq Biotechnology's market value can be influenced by many factors that don't directly affect Nasdaq Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nasdaq Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine Nasdaq Biotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nasdaq Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.